← Open Payments lookup

THOMAS GRANT: Open Payments

NPI 1316587207 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$630 in 14 payments from 7 companies in 2025. Trend: 2023 $216 · 2024 $1,050 · 2025 $630

Food & beverage: $630
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.1$174
Otsuka America Pharmaceutical, Inc.1$123
Alkermes, Inc.4$112
Janssen Pharmaceuticals, Inc2$94
ABBVIE INC.3$65
Teva Pharmaceuticals USA, Inc.2$45
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$18

Products named: INGREZZA, ABILIFY MAINTENA, ARISTADA, INVEGA SUSTENNA, VRAYLAR, UZEDY, AUSTEDO XR, CAPLYTA.

Industry payments across NY — which companies pay providers there.